Skip to main content

Table 3 Distribution of patients by REVEAL risk categories at baseline and ≥ 6-month time points in patients on macitentan

From: Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study

 ≥6-month 
Baseline1–78910–11≥12Total
1–712200014
85230010
93360012
10–114435117
≥12101204
Total2511137157
  1. Risk categories: 1–7 low risk, 8 average risk, 9 moderate high risk, 10 or 11 high risk, and ≥ 12 very high risk